ALNYLAM PHARMACEUTICALS, INC. Increase (Decrease) in Income Taxes Receivable
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Increase (Decrease) in Income Taxes Receivable of $0 for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2014-02-20
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes receivable for the quarter ending 2012-06-30 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes receivable for the quarter ending 2012-03-31 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes receivable for the quarter ending 2011-12-31 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes receivable for the quarter ending 2011-09-30 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes receivable for fiscal 2011 was -$10.67M, a 200.00% decline from fiscal 2010.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes receivable for fiscal 2010 was $10.67M.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $0.00 10-Q · filed 2012-08-08 | $0.00 derived: sum of 3 quarters · filed 2014-02-20 | $0.00 derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-03 | $0.00 derived: sum of 2 quarters · filed 2014-02-20 | $0.00 derived: sum of 3 quarters · filed 2014-02-20 | $0.00 derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $0.00 derived: sum of 2 quarters · filed 2014-02-20 | $0.00 derived: sum of 3 quarters · filed 2014-02-20 | -$10.67M 10-K · filed 2014-02-20 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $0.00 derived: sum of 2 quarters · filed 2012-11-05 | -$10.67M 10-Q · filed 2012-11-05 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$10.67M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | -$10.67M 10-Q · filed 2012-05-03 | |||
| 2010-12-31 | $10.67M 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |